Gene Query: NEO1

Dataset Description Geneva Score
RNA-seq of human fibroblasts after irradiation 123.34
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 78.76
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 52.3
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 48.59
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 46.15
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 45.73
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 45.22
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 41.34
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 41.31
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 39.75
Investigation about fibroblasts of different origins in culture 39.45
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 38.57
SRSF2 mutations impair hematopoiesis and alter exon recognition 37.91
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 37.49
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 36.7
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 36.04
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 34.51
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 34.44
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 34.37
RNA-seq of stable and unstable section of human atherosclerotic plaques 31.92
METTL3 promotes translation in human cancer cells 31.4
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 30.87
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 30.74
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 30.58
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 30.44
DJ-1 is dispensable for human stem cell homeostasis 30.41
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 29.78
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 29.54
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 27.61
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 26.67
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 26.6
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 26.57
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 26.4
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 26.28
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 26.11
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 26.11
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 26.01
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 25.98
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 25.98
Identifying the molecular mode of action of itraconazole in colorectal cancer 25.52
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 25.06
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 25.01
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 25.01
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 24.76
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 24.62
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 24.62
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 24.09
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 23.72
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 23.53
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 23.48
Differentially expressed genes post knock down of lincDUSP26 22.64
High-Throughput Kinetic Analysis of Fractional Killing 22.12
Gene expression changes upon drug withdrawal (Mel888 cell line) 22.01
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 21.72
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 21.72
RNAseq of T-ALL upon long non coding rna purturbation 21.58
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 21.28
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 21.25
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 21.05
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 20.84
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 20.72
Genome-wide functional assessment of enhancer activities in the human genome 20.72
snRNAs as regulators of alternative splicing 20.33
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 20.17
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 19.78
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 19.36
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 19.28
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 18.98
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 18.98
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 18.97
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 18.77
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 18.65
Differential analysis of gene regulation at transcript resolution by RNA-Seq 18.59
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 18.59
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 18.52
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 18.52
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 18.51
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 18.49
PNET animal model: new insights (II) 18.49
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 18.49
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 18.48
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 18.39
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 18.3
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 18.13
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 18.1
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 18.04
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 17.95
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 17.82
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 17.65
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 17.52
A549 cells and MSR-A549 cells 17.52
Differential gene expression profiles in imatinib-resistant cell lines 17.51
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 17.51
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 17.49
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 17.49
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 17.36
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 17.22
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 17.22
Global analysis of alternative splicing regulated by RBM10 17.16
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 17.15
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 16.99
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 16.99
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 16.98
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 16.94
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 16.73
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 16.71
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 16.61
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 16.61
Differentially expressed vascular development genes for iPSC-ECs from CDI 16.49
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 16.18
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 15.96
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 15.96
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 15.9
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 15.69
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 15.66
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 15.43
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 15.36
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 15.22
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 15.22
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 15.17
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 15.17
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 15.03
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 14.97
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 14.96
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 14.96
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 14.85
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 14.85
Lineage specific differentiation is influenced by state of human pluripotency 14.85
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 14.75
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 14.65
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 14.65
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 14.49
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 14.49
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 14.38
RNA-seq of naive and primed ES cells (NHSM) 14.32
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 14.3
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 14.28
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 14.25
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 14.07
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 14.07
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 13.89
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 13.67
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 13.65
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 13.52
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 13.51
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 13.46
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 13.46
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 13.41
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 13.41
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 13.39
RNA-seq of human aneuploid cell lines with Trisomy 21 13.31
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 13.27
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 13.27
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 13.16
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 13.12
Effect of Hotair overexpression in human breast cancer cell lines 13.11
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 13.03
Gene expression analysis of immortalized human liver progenitor-like cells in culture 13.01
Identification of Sin3B regulated genes during quiescence 12.96
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 12.96
Epigenomic landscape during organ formation in human early embryos 12.96
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 12.94
IRF2 is a master regulator of human keratinocyte stem cell fate 12.94
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 12.91
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 12.89
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 12.88
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 12.84
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 12.84
Functional role of SLIT2 and ROBO1 in trophoblasts 12.82
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 12.71
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 12.71
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 12.68
MEIS1 regulates hematopoiesis in hPSCs 12.68
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 12.6
Gene expression changes in human melanoma cell lines compared to primary melanocytes 12.59
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 12.54
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 12.54
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 12.53
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 12.5
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 12.47
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 12.45
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 12.36
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 12.32
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 12.32
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 12.27
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 12.24
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 12.24
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 12.21
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 12.17
Tyrosine Kinase Inhibitor Cardiotoxicity 12.17
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 12.07
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 12.04
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 11.98
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 11.97
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 11.93
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 11.91
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 11.82
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 11.78
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 11.78
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 11.77
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 11.7
Transcriptional profiling of microglia; current state of the art and future perspectives 11.7
RNA expression following TMPRSS11B overexpression or depletion 11.67
Silencing SPIB in attached and floating state of H1703 lung cancer cells 11.66
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 11.65
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 11.63
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 11.59
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 11.58
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 11.54
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 11.54
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 11.47
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 11.46
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 11.46
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 11.37
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 11.33
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 11.28
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 11.26
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 11.24
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 11.22
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 11.21
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 11.2
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 11.17
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 11.06
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 11.02
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 11.02
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 10.98
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 10.97
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 10.88
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 10.83
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 10.83
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 10.79
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 10.78
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 10.75
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 10.75
RNA-seq of naive and primed ES cells 10.7
HNF1A deficiency impairs β-cell fate, granule maturation and function 10.64
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 10.57
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 10.52
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 10.49
An siRNA screen identifies CHD4 as a target for epigenetic therapy 10.43
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 10.42
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 10.39
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 10.39
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 10.34
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 10.34
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 10.24
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 10.24
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 10.2
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 10.2
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 10.2
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 10.16
Effect of disulfiram treatment on pediatric high grade glioma 10.05
Transcriptome analysis of virus infected tissues 10.04
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 10.02
Neurofibroma 10.02
The effect of PPARG inhibition on human angiomyolipoma cells 10.02
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 9.99
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 9.98
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 9.97
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 9.97
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 9.96
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 9.96
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 9.95
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 9.95
Metabolism as an early predictor of DPSCs aging 9.91
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 9.9
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 9.9
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 9.9
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 9.89
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 9.88
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 9.81
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 9.8
Next Generation Sequencing of human SMA and healthy control Motor Neurons 9.78
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 9.7
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 9.69
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 9.67
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 9.67
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 9.66
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 9.6
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 9.56
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 9.54
AMPK signaling for naïve pluripotency 9.46
AMPK signaling for naïve pluripotency [Hs] 9.46
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 9.43
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.42
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.42
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 9.41
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 9.36
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 9.29
PGE2 mediated gene expression changes in human cervical stromal cells 9.22
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 9.22
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 9.22
Differential Gene Expression between MCF10A and MCF7 cells 9.2
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 9.09
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 9.04
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 9.02
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 8.99
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 8.91
Functional astrocytes differentiated from hiPSCs 8.77
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 8.62
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 8.56
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 8.56
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 8.53
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 8.53
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 8.5
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 8.42
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 8.41
Transcriptional effect of ETV1 knockdown in melanoma cells 8.33
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 8.18
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 8.17
Gene expression of thyroid cancer cell lines 8.1
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 8.1
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 8.04
Conservative alteration of chromosomal expression pattern across human solid tumor types 7.99
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 7.95
iPSC-Derived Cholangiocytes 7.93
mRNA sequencing of oropharyngeal cancer cell lines 7.9
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 7.87
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 7.79
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 7.74
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 7.74
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 7.74
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 7.74
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 7.73
Expression profiling of etoposide-induced senescent cells 7.72
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 7.7
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 7.68
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 7.64
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 7.53
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 7.48
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 7.46
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 7.37
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 7.34
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 7.34
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 7.31
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 7.31
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 7.24
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 7.21
Gene expression alterations of pancreatic intraepithlial neoplasia 7.16
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 7.14
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 7.09
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 7.04
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 6.99
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 6.86
An acquired vulnerability of drug resistant melanoma with therapeutic potential 6.86
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 6.84
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 6.78
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 6.74
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 6.65
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 6.6
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 6.6
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 6.54
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 6.54
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 6.44
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 6.33
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 6.32
Aortic Valve Tissue: Stenosis vs. Sclerosis 6.26
ARID1A and ARID1B loss in HCT116 and TOV21G cells 6.24
Gene expression profile of CRC-derived HILEC 6.23
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 6.15
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 6.13
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 6.12
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 6.1
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 6.09
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.92
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 5.88
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.83
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 5.8
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 5.72
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 5.64
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 5.64
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 5.62
RNA sequencing of human pancreatic cancer cell lines 5.59
Genome-wide identification of cancer-specific alternative splicing in circRNA 5.44
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 5.39
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 5.39
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 5.27
RNA-sequencing 5.26
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 5.26
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 5.25
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 5.17
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 5.13
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 4.98
The Genomic Landscape of Atypical Fibroxanthoma 4.97
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 4.85
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 4.82
PRDM1 inhibits proliferation of human colon cancer organoids 4.77
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 4.76
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 4.65
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 4.46
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 4.38
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 4.34
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.31
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.31
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 3.98
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 3.95
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 3.78
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 3.76
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 3.76
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 3.75
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 3.75
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.75
RNAseq analysis of ruxolitinib treated breast cancers 3.73
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 3.59
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 3.57
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 3.57
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.56
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.54
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.51
In vitro modeling of human germ cell development using pluripotent stem cells 3.46
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 3.41
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 3.41
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 3.39
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 3.32
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 3.32
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 3.25
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 3.21
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 3.17
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 3.05
Genome-wide Analysis of Chromatin Interactions in Human Cells 2.95
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 2.86
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 2.85
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.84
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 2.8
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 2.71
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.7
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 2.66
Molecular Criteria for Defining the Naive Human Pluripotent State 2.57
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.56
The DPYSL2 gene connects mTOR and schizophrenia 2.48
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.45
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.45
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 2.37
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 2.33
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 2.33
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.26
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.26
Ribosomal protein RPL26 is the principal target of UFMylation 2.11
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 2.09
The circadian transcriptional landscape in primary human mammary epithelial cells 2.04
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.03
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.72
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.66
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.66
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.64
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.64
RNA-seq analysis of the human fetal kidney. 1.62
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 1.56
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.5
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.49
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.49
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.38
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.3
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.3
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.28
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.25
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.12
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 1.08
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.07
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.03
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.99
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.99
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.89
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.88
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.83
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.83
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 0.82
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.81
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.8
Effects of transcription on genome - nuclear lamina interactions 0.8
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.72
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.72
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.68
Zika virus directly infects human peripheral neurons and induces cell death 0.66
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.59
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.56
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.53
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.52
Activity-dependent transcriptional changes in human neurons 0.47
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.46
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.46
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.45
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.42
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.38
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.38
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.31
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 0.26
Transcriptome-wide response to synthetic chromatin protein PcTF 0.24
Determining mRNA half-lives on a transcriptome-wide scale 0.23
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.21
BMS-470539 on human synovial fibroblasts 0.18
Gene expression profiling of KSHV-infected periodontal ligament cells 0.17
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.14
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.14
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 0.11
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 0.11
NHLRC1 re-expression in cancer cells 0.11
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.09
KLF6-dependent transcription in renal cancer cells 0.05
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation